127
Participants
Start Date
October 31, 2009
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Placebo of CDP870
Given every 2 weeks until Week22 (SC)
CDP870 200mg
400mg CDP870 given at Week0, 2, 4 and thereafter 200mg CDP870 given every 2 weeks until Week 22(SC)
Methotrexate
"Received treatment with Methotrexate(MTX)for at least 24 weeks prior to the Baseline Visit.~The dose and route of administration of MTX had to have been stable for at least 8 weeks prior to the Baseline Visit. The minimum stable dose of MTX allowed is 10mg weekly."
Kyungpook National University Hospital, Daegu
Catholic University Hospital of Daegu, Daegu
Inha University Hospital, Inchon
Chonnam National University Hospital, Kwangju
Pusan National University Hospital, Pusan
Gangnam Severance Hospital, Seoul
Hanyang Universoty Hospital, Seoul
KonKuk University Medical Center, Seoul
Seoul national univeristy, Seoul
Ajou University Hospital, Suwon
Eulji University Hospital, Daejeon
Yonsei University Severance Hospital, Seoul
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Catholic University of Korea ST.Mary's Hospital, Seoul
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY